Sales revenues for April 2019

  Sofia, Bulgaria, May 7, 2019 - Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for April 2019 the Company recorded a decrease of sales revenues of 7% compared to the same month of 2018, incl. keeping the sales for the domestic market and a decrease of 11% of export sales.

  In the first four months of 2019 the revenues from sales of production decreased by 3% compared to the same period of 2018, including 15% decrease in domestic sales and 5% increase of export sales.